Background Image
Table of Contents Table of Contents
Previous Page  95 / 132 Next Page
Information
Show Menu
Previous Page 95 / 132 Next Page
Page Background

95

ୋɚືcᏨ᜕਷ყʷ

ر

͉໇ጐ฽ၾ΋ආ਷࢕Ꮸ᜕ዚ࿴

ܔ

ͭྼሯΥЪᗫ

ڷ

dኪ୦Ԩіϗ௰อҦஔd˸л೯࢝

ၾ਷ყΝӉʘᏨ᜕ҦஔdԨᑘ፬਷ყ޼ীึ࢝ତੂБ຾᜕d౤ʺҢ਷޼೯ʘᏨ᜕ঐඎf

݁ഄၾϓ

؈

ɓe ࠮ۜჯਹ

€ɓଉʷၾ

ߕ

਷࠮ۜᖹ

၍ي

ଣ҅€

FDA

ʘ

ΥЪ

1.

׵

100

Ї

101

ϋ

ݼ

ࡰЇ

ߕ

FDA

࠮ۜτ

Όၾᐄቮʕː€

CFSAN

ආБ

މ

ɓϋٙ΍Ν޼Ӻ

೥dϤ

ܝ

੻˸ᒗሗ

CFSAN

༵ᖹᏨ᜕ʃଡ଼

பɛ

Jon Wong

௹ɻԸၽdආБ࠮ۜᏨ᜕Ҧஔʹ

ݴ

f

2. 102

ϋϋ

ڋ

਷ყග೯͛ॲГᚆ̲४ဲӴ᜕ўϞᕐ↾ᶶ€

DCD

ԫ΁dΝϋֵ

਷lzᖑ೯

ذ

ۜʕဲЧ૴̋ზ໢ၠ९ԫ΁dԫ΁೯͛຅ࣛѩஹᖩ

ߕ

FDA

ਖ਼࢕d

՘п͉໇Ҟ஺ΪᏐdՈ᜗༺ϓᏨ᜕਷ყʷʘͦٙf

€ɚܵᚃਞၾ˜ʮ֛ʱؓʷኪ࢕՘ึ€

AOAC

™

AOAC

݊਷ყගᗫ׵࠮ۜτΌᏨ᜕ʘᛆ

۾

ଡ଼ᔌd͉໇

ڐ

ϋԸӊϋѩ

ݼ

ࡰ̈ࢩί

ߕ

਷ᑘБʘϋึdீཀɹ᎘စႭʿኣజሞ˖೯

ڌ

d࢝ତ͉໇޼ӺᏨ᜕ϓ

؈

dԨၾ਷

ყਖ਼࢕ʹ

ݴ

ʝਗfϤ̮dӊϋ

ߕ

਷ϋึޫᚠϞਖ਼᙮ࣛ

ݬ

ʿึᙄ܃Զၽᝄʱึᑘ፬ึ

ᙄdᜑͪ

ߕ

AOAC

ᐼึ࿁ၽᝄʘࠠൖf

ɚe ᖹۜჯਹ

€ɓ

102

ϋගᐏᒗਞၾ

WHO

ਜਹΥЪʕː€

WHO Collaborating Center



ߵ

਷਷࢕͛

ي

Ⴁኒᅺ๟࿬၍Փ޼Ӻ

ה

€

National Institute for Biological Standards and Control,

NIBSC

ᑘ፬ʘ˜

3rd WHO International Standard for B19V for NAT-based assays

™

ʿ˜

2nd WHO International Standard for HAV for NAT-based assays

™਷ყ΍Νᅺ

֛޼Ӻf

€ɚ͉໇׵

102

ϋ

5

˜

29-31

˚ᑘ፬˜

2013

਷ყ

ߴޥ

Ꮸ᜕ʿ޼೯อҦஔ™਷ყ޼ীึd

ึʕᒗሗ

ج

eˢe˚e൳ʿ਷lzਖ਼࢕ఱɛळ΍ஷෂ

ݑ

षʘ

ݴ

Бषኪeอ

ߴޥ

޼೯e

ۜሯᏨ᜕e͛

ي

ʱؓᏐ͜ʿၽᝄ

ߴޥ

͛

ي

ᖹۜۜ၍Ꮸ᜕ၾ༟ৃ၍ଣӻ୕ഃᙄ

ᕚආБစᑺdԨၾ਷lz˴၍ዚᗫʿପኪ޼΢

ޢ

ආБҦஔʹ

ݴ

f

Jon Wong

௹ɻႇ໇ආБ࠮ۜᏨ᜕Ҧஔʹ

ݴ